Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Borris

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Seminars in Thrombosis and Hemostasis|November 5, 1999
Deep-vein thrombosis prophylaxis in orthopedic surgery: hip surgeryM R Lassen, S Backs, L C Borris, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1990
Levels of thrombin--antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low-molecular-weight heparinJ V Sørensen, L C Borris, M R Lassen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplastyM R Lassen, L C Borris, H P Jensen, et al.
Thrombosis Research|March 1, 1992
Markers of coagulation and fibrinolysis after fractures of the lower extremitiesJ V Sørensen, H B Rahr, H P Jensen, et al.
Ugeskrift for Laeger|July 3, 1989
[Dihydroergotamine and orthostatic hypotension in elective hip surgery]V E Hjortdal, B W Nielsen, F Møller-Larsen, et al.
Ugeskrift for Laeger|April 12, 1993
[Low molecular heparin in prevention of thrombosis in orthopedic surgery]H P Jensen, L C Borris, M R Lassen, et al.
Thrombosis Research|July 1, 1990
Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis GroupJ V Sørensen, L C Borris, M R Lassen, et al.
Haemostasis|January 1, 1992
Potential influence of observer variation in thromboprophylactic trialsP Wille-Jørgensen, L C Borris, M R Lassen, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up studyB S Andersen, H P Jensen, L C Borris, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparinJ V Sørensen, M R Lassen, L C Borris, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Seminars in Thrombosis and Hemostasis|November 5, 1999
Deep-vein thrombosis prophylaxis in orthopedic surgery: hip surgeryM R Lassen, S Backs, L C Borris, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1990
Levels of thrombin--antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low-molecular-weight heparinJ V Sørensen, L C Borris, M R Lassen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplastyM R Lassen, L C Borris, H P Jensen, et al.
Thrombosis Research|March 1, 1992
Markers of coagulation and fibrinolysis after fractures of the lower extremitiesJ V Sørensen, H B Rahr, H P Jensen, et al.
Ugeskrift for Laeger|July 3, 1989
[Dihydroergotamine and orthostatic hypotension in elective hip surgery]V E Hjortdal, B W Nielsen, F Møller-Larsen, et al.
Ugeskrift for Laeger|April 12, 1993
[Low molecular heparin in prevention of thrombosis in orthopedic surgery]H P Jensen, L C Borris, M R Lassen, et al.
Thrombosis Research|July 1, 1990
Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis GroupJ V Sørensen, L C Borris, M R Lassen, et al.
Haemostasis|January 1, 1992
Potential influence of observer variation in thromboprophylactic trialsP Wille-Jørgensen, L C Borris, M R Lassen, et al.
The International Journal of Risk & Safety in Medicine|March 21, 2013
Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up studyB S Andersen, H P Jensen, L C Borris, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1992
Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparinJ V Sørensen, M R Lassen, L C Borris, et al.
Pageof 5